March 27, 2025With 67 ownership Pfizer Inc. NYSE:PFE boasts of strong institutional backing ~1 min.Pfizer Inc., a renowned pharmaceutical company, is currently enjoying the support of strong institutional investors with a significant 67% ownership....
March 21, 2025Analyst Says Pfizer PFE Stock Will Move Too Fast to Catch ~1 min.According to recent analysis by Stocks Prognosis, Pfizer Inc. (NYSE:PFE) is expected to experience significant movement in its stock price in the near future....
March 20, 2025Pfizer Inc. PFE: Pioneering a New Era in Healthcare Innovation ~2 min.Pfizer Inc., a renowned pharmaceutical company, continues to revolutionize the healthcare industry with its groundbreaking innovations....
March 19, 2025Is Pfizer Inc. PFE the Best Pharma Stock to Buy According to Hedge Funds ~1 min.Pfizer Inc. (PFE) has become a subject of interest for investors and hedge funds in the pharmaceutical industry....
March 16, 2025Pfizer Inc. PFE Shows Promising Results in Collaboration with Arvinas ~2 min.Pfizer Inc. (PFE), one of the leading pharmaceutical companies, recently announced the positive topline results from its collaboration with Arvinas....
February 10, 2025Regeneron Pharmaceuticals Inc REGN Q4 2024 Earnings Call Highlights: Strong Revenue Growth ... Yahoo Finance ~1 min.Regeneron Pharmaceuticals Inc. (REGN) recently held its Q4 2024 earnings call, highlighting strong revenue growth and positive developments in its portfolio....
February 9, 2025Regeneron Pharmaceuticals Inc REGN Reports Strong Earnings in Q4 2024 ~2 min.Regeneron Pharmaceuticals Inc., a leading biotechnology company, announced its impressive financial results for the fourth quarter of 2024....
November 27, 2024AbbVie Executives to Present at Citi's 2024 Global Healthcare Conference ~1 min.AbbVie Inc. (ABBV) has announced that its executives will be presenting at Citi's 2024 Global Healthcare Conference....
November 7, 2024Merck & Co. Inc. MRK Executives Set to Share Strategic Insights at UBS Healthcare Conference ~2 min.Merck & Co. Inc. (MRK) executives are gearing up to participate in the prestigious UBS Global Healthcare Conference, where they will be sharing their strategic insights and plans for the future....
January 2, 2025Regeneron Pharmaceuticals: An Impressive 89% Return Over the Last Five Years ~2 min.Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has been a rewarding investment for shareholders, with a solid 89% return over the past five years, according to Yahoo Finance....
